News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
793,370 Results
Type
Article (73134)
Company Profile (622)
Press Release (719614)
Section
Business (225714)
Career Advice (3679)
Deals (39041)
Drug Delivery (106)
Drug Development (88373)
Employer Resources (192)
FDA (17569)
Job Trends (16998)
News (384177)
Policy (38439)
Tag
Academia (2972)
Africa (1178)
Alliances (55365)
Alzheimer's disease (1248)
Approvals (17478)
Arizona (190)
Artificial intelligence (86)
Asia (47108)
Australia (8077)
Bankruptcy (389)
Best Places to Work (12257)
Biotechnology (438)
C2C Services and Suppliers (91796)
California (2023)
Canada (945)
Cancer (542)
Career advice (3128)
Cell therapy (142)
China (157)
Clinical research (68908)
Collaboration (154)
Colorado (83)
Compensation (82)
Connecticut (84)
COVID-19 (2754)
Cystic fibrosis (77)
Data (313)
Diabetes (92)
Diagnostics (6499)
Drug pricing (84)
Earnings (90220)
Employer resources (162)
Europe (106613)
Events (123697)
Executive appointments (159)
FDA (17801)
Florida (273)
Funding (154)
Gene therapy (108)
GLP-1 (617)
Government (4958)
Healthcare (20640)
Hotbed/Location (523822)
Illinois (310)
Indiana (161)
Infectious disease (2785)
Inflammatory bowel disease (102)
Interviews (719)
IPO (17393)
Job creations (4925)
Job search strategy (2577)
Kansas (99)
Layoffs (466)
Legal (9775)
Lung cancer (125)
Manufacturing (101)
Maryland (432)
Massachusetts (1719)
Medical device (14256)
Medtech (14261)
Mergers & acquisitions (21482)
Metabolic disorders (297)
Michigan (137)
Minnesota (236)
Neuroscience (1415)
New Jersey (617)
New York (622)
NextGen Class of 2024 (7593)
Non-profit (5052)
North Carolina (701)
Northern California (842)
Obesity (178)
Ohio (110)
Opinion (234)
Patents (78)
Pennsylvania (596)
People (62276)
Pharmaceutical (119)
Phase I (21197)
Phase II (30060)
Phase III (22731)
Pipeline (111)
Podcasts (75)
Postmarket research (3216)
Preclinical (9341)
Press Release (72)
Rare diseases (141)
Real estate (7079)
Recruiting (72)
Regulatory (24741)
Research institute (2633)
Resumes & cover letters (575)
South America (1551)
Southern California (776)
Startups (4164)
Texas (266)
United States (9342)
Vaccines (567)
Washington State (282)
Weight loss (170)
Date
Today (186)
Last 7 days (745)
Last 30 days (2539)
Last 365 days (40007)
2024 (28120)
2023 (42565)
2022 (53927)
2021 (58725)
2020 (57668)
2019 (51305)
2018 (39085)
2017 (36798)
2016 (37687)
2015 (43689)
2014 (38254)
2013 (34209)
2012 (36150)
2011 (36224)
2010 (35523)
793,370 Results for "co diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Co-Diagnostics, Inc. today announced that last month the Board of Directors appointed Richard Abbott as President of Co-Diagnostics, Inc., concurrent with the Company naming David Nielsen to be its Chief Operations Officer (COO), Christopher Thurston as its Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO).
April 4, 2024
·
5 min read
BioMidwest
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Co-Diagnostics, Inc. announced that Co-Dx CEO Dwight Egan will deliver the keynote address at the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets and held March 21-22, 2024, in London, England.
March 18, 2024
·
2 min read
BioMidwest
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. announced that it held the ribbon cutting event for its new manufacturing facility yesterday in the City of South Salt Lake.
April 12, 2024
·
3 min read
BioMidwest
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. announced that the Company will be hosting a booth and delivering a presentation at the 9th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease on April 26-29, 2024 in Taipei, Taiwan.
April 24, 2024
·
2 min read
Business
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the full year ended December 31, 2023.
March 14, 2024
·
11 min read
Business
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
August 8, 2024
·
10 min read
1 of 79,337
Next